- Home
- CLDX vs IOSP Comparison
CLDX vs IOSP Comparison
Compare CLDX & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | IOSP |
|---|---|---|
| Founded | N/A | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1995 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CLDX | IOSP |
|---|---|---|
| Price | $29.27 | $82.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $46.60 | ★ $93.00 |
| AVG Volume (30 Days) | ★ 692.1K | 159.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | ★ 228.87 |
| EPS | N/A | ★ 1.22 |
| Revenue | $12,743,000.00 | ★ $1,778,000,000.00 |
| Revenue This Year | $111.39 | $5.96 |
| Revenue Next Year | $235.85 | $6.10 |
| P/E Ratio | ★ N/A | $67.89 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $19.52 | $65.51 |
| 52 Week High | $35.83 | $92.14 |
Technical Indicators
Market Signals| Indicator | CLDX | IOSP |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 63.58 |
| Support Level | $28.55 | $75.15 |
| Resistance Level | $30.90 | $92.14 |
| Average True Range (ATR) | 1.04 | 1.75 |
| MACD | -0.20 | -0.05 |
| Stochastic Oscillator | 22.48 | 94.13 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.